-
3 Articles
-
1 Photos
-
0 Vidéos
-
Protheragen à Protheragen
-
Habitant New York
-
Du New York
-
Étudié NO à NOClasse de NO
-
Male
-
Suivi par 0 membre
Mises à jour récentes
-
The Preclinical Foundation: How Obesity Models Drive Therapeutic BreakthroughsThe global escalation of metabolic disorders has transformed obesity from a secondary health concern into a primary clinical challenge, necessitating a more sophisticated approach to pharmaceutical intervention. While the ultimate goal of any therapeutic is successful human application, the high rate of attrition in clinical trials underscores the critical need for a robust preclinical...0 Commentaires 0 Parts 166 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
Protheragen Obesity Announces Full Preclinical Services and Research Products for Obesity Drug DevelopmentDeveloping a new obesity drug requires multiple steps: target validation, pharmacokinetic studies, safety assessments, and more. Protheragen Obesity is a Contract Research Organization (CRO) that provides exactly these services, with a focus on the preclinical stage. The company recently announced its full range of service offerings and research products. According to its website,...0 Commentaires 0 Parts 174 Vue 0 Aperçu
-
0 Commentaires 0 Parts 76 Vue 0 Aperçu
Plus de lecture